TransPharma-Medical Ltd., the Israeli-based biopharmaceutical company that develops pharmaceutical products utilizing its unique transdermal RF-MicroChannels™ transdermal drug delivery technology , announces today it has received its first milestone payment from Teva Pharmaceuticals for successfully completing the first clinical trials, based on a joint development agreement originally signed between the two companies in 2004.
